LEVY ALAN J
Known title: DirectorCIK: 0001280627
Associated companies
Transaction History
| ISRG | ▲ Buy | Option Exercise | 569 | $0 | 4/25/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,000 | $308K | 4/23/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,000 | $741K | 4/23/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 72 | $11K | 1/26/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 72 | $27K | 1/26/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 1,928 | $174K | 1/26/2024 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,928 | $714K | 1/26/2024 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 2,000 | $181K | 11/14/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 2,000 | $580K | 11/14/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 1,535 | $139K | 8/7/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 1,535 | $476K | 8/7/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 465 | $33K | 8/7/2023 | View on chart |
| ISRG | ▼ Sell | Open Market | 465 | $144K | 8/7/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 482 | $0 | 4/27/2023 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 555 | $0 | 4/22/2022 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 3,000 | $214K | 10/22/2021 | View on chart |
| ISRG | ▼ Sell | Open Market | 3,000 | $1.0M | 10/22/2021 | View on chart |
| ISRG | ▲ Buy | Option Exercise | 4,500 | $256K | 10/22/2021 | View on chart |
| ISRG | ▼ Sell | Open Market | 4,500 | $1.5M | 10/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition
Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition. Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.